476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19

476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19

Bibliographic Details
Main Authors: Na Chen, Tingting Zhong, Zhaoliang Huang, Xinghua Pang, Konyew Kwek, Chris Wynne, Adam Konpa, Maxwell Zhongmin Wang
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-f6d4c3e228d24c228472c5c55053e4be
record_format Article
spelling doaj-f6d4c3e228d24c228472c5c55053e4be2020-12-11T10:02:16ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0476476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19Na Chen0Tingting Zhong1Zhaoliang Huang2Xinghua Pang3Konyew Kwek4Chris Wynne5Adam Konpa6Maxwell Zhongmin Wang7Aff1 0000 0004 1760 6682grid.410570.7National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of PharmacyThird Military Medical University No.30 Gaotanyan Street 400038 Chongqing China 1Akeso Biopharma Co., Ltd., Zhongshan city, China1Akeso Biopharma Co., Ltd., Zhongshan city, China1Akeso Biopharma Co., Ltd., Zhongshan city, China1Akeso Biopharma Co., Ltd., Zhongshan city, China2Christchurch Clinical Studies Trust Ltd., Christchurch, New Zealand1Akeso Biopharma Co., Ltd., Zhongshan city, China1Akeso Biopharma Co., Ltd., Zhongshan city, China
collection DOAJ
language English
format Article
sources DOAJ
author Na Chen
Tingting Zhong
Zhaoliang Huang
Xinghua Pang
Konyew Kwek
Chris Wynne
Adam Konpa
Maxwell Zhongmin Wang
spellingShingle Na Chen
Tingting Zhong
Zhaoliang Huang
Xinghua Pang
Konyew Kwek
Chris Wynne
Adam Konpa
Maxwell Zhongmin Wang
476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
Journal for ImmunoTherapy of Cancer
author_facet Na Chen
Tingting Zhong
Zhaoliang Huang
Xinghua Pang
Konyew Kwek
Chris Wynne
Adam Konpa
Maxwell Zhongmin Wang
author_sort Na Chen
title 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
title_short 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
title_full 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
title_fullStr 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
title_full_unstemmed 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
title_sort 476 ak119, a humanized anti-cd73 monoclonal antibody, as immunotherapy for covid-19
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT nachen 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT tingtingzhong 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT zhaolianghuang 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT xinghuapang 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT konyewkwek 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT chriswynne 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT adamkonpa 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
AT maxwellzhongminwang 476ak119ahumanizedanticd73monoclonalantibodyasimmunotherapyforcovid19
_version_ 1724386628084957184

Similar Items